Header image for Welcome to the Swedish Pavilion at BIO International 2026!


 WHY SWEDEN

International companies choose Sweden for its depth, credibility, and ability to deliver across the full innovation lifecycle. With high R&D investment, a strong pharmaceutical pipeline, and world-class institutions, Sweden translates research excellence into investable opportunities. 




3.6% of GDP in R&D
Sweden invests over 3% of its GDP in research and development, placing it among the world's leading innovation nations and fuelling breakthroughs across biotechnology, pharmaceuticals, and medtech

Home of the Nobel Prize
Sweden has a long-standing tradition of scientific excellence, anchored by Karolinska Institutet, which has been responsible for awarding the Nobel Prize in Physiology or Medicine since 1901.

Top 10 in hospital ranking
Sweden's data-rich healthcare system enables real-world evidence generation and translational research. Karolinska University Hospital is consistently ranked among the world's top hospitals and the highest-ranked in Europe

Hej! #JoinSweden
Sweden actively fosters global partnerships, participates strongly in EU research programmes, and offers an open ecosystem for foreign investment, international talent, and cross-border innovation




 


Are you an international company looking to grow and invest in Sweden?

Connect with Paul Majewski to explore opportunities and partnerships.

paul.majewski@business-sweden.se